Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VBaP vs Danazol in Low-risk MDS
NCT04997811Phase 2Unknown
- Start
- Dec 2021
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of valproic acid, bezafibrate, medroxyprogesterone acetate in myelodysplastic syndrome (MDS). Status: unknown.
02
Drugs
valproic acidbezafibratemedroxyprogesterone acetate
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT04997811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04997811.